Doctor profile · Federal record

Dr. Wajeeha Razaq, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Hematology & Oncology Physician · Oklahoma City, OK

  • NPI 1265619530
  • Accepts Medicare
  • MIPS 71.7 / 100 · 2023
  • 27 yrs in practice
  • Licensed in 2 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
800 Ne 10Th St
Oklahoma City, OK 731045418
(405) 271-4022
fax (405) 271-4221

Credentials & registration

NPPES · NUCC
NPI registered
January 2008 — 18 yrs on file
Profile last updated
August 16, 2012
Year of graduation
1999 — 27 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State licenses (2)
Oklahoma #28993 · Nebraska #24693

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1265619530. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
460
Distinct HCPCS
5
Medicare allowed
$49,136
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 260 172 $93
99215 Established patient office or other outpatient visit, 40-54 minutes 107 67 $134
99205 New patient office or other outpatient visit, 60-74 minutes 49 49 $174
G0444 Annual depression screening, 5 to 15 minutes 29 29 $9
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes 15 15 $125

In context: peer comparison

Among 24 peers in this city , average services per provider: 459. This provider delivers 1.0× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$739
Transactions
36
Manufacturers
12
Payer (manufacturer) Industry Txns Amount
Daiichi Sankyo Inc. 6 $208.15
Merck Sharp & Dohme LLC 7 $141.79
PFIZER INC. 6 $60.72
Novartis Pharmaceuticals Corporation 3 $51.08
AstraZeneca Pharmaceuticals LP 3 $49.38
TerSera Therapeutics LLC 2 $47.81
Gilead Sciences, Inc. 2 $43.92
Genentech USA, Inc. 2 $41.18
Lilly USA, LLC 2 $35.06
Menarini Silicon Biosystems, Inc. 1 $26.95
Genmab U.S., Inc. 1 $18.56
PUMA BIOTECHNOLOGY, INC. 1 $14.67

By nature of payment

Food and Beverage
$679
Education
$61

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
1,376
Patients
317
Total drug cost
$4,856,603
Drug Type Claims Patients Total cost
Anastrozole Generic 470 146 $12,449
Ibrance (Palbociclib) Brand 160 20 $2,513,976
Letrozole Generic 131 38 $4,208
Exemestane Generic 121 32 $19,603
Verzenio (Abemaciclib) Brand 78 0 $1,193,233
Gabapentin Generic 73 19 $1,230
Ondansetron Hcl Generic 58 29 $3,768
Kisqali (Ribociclib Succinate) Brand 53 0 $754,642
Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) Brand 41 0 $617
Lidocaine-Prilocaine (Lidocaine/Prilocaine) Brand 41 20 $861

Frequently asked questions

Auto-generated from federal data
What is Dr. Wajeeha Razaq's medical specialty?
Dr. Wajeeha Razaq practices Hematology & Oncology Physician in Oklahoma City, OK.
Where does Dr. Wajeeha Razaq practice?
Dr. Wajeeha Razaq practices at 800 Ne 10Th St, Oklahoma City, OK 731045418. Office phone: 4052714022.
What is Dr. Wajeeha Razaq's NPI?
Dr. Wajeeha Razaq's National Provider Identifier (NPI) is 1265619530, issued by NPPES.
Does Dr. Wajeeha Razaq accept Medicare assignment?
Yes. Dr. Wajeeha Razaq accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Wajeeha Razaq commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215); New patient office or other outpatient visit (HCPCS 99205). Source: CMS Medicare Physician & Other Practitioners file.